William D. Turner — Senior Vice President of Global Regulatory Affairs and Quality Assurance at Aimmune Therapeutics

Mr. William D. Turner has been Senior Vice President of Global Regulatory Affairs and Quality Assurance at Aimmune Therapeutics, Inc. since February 23 2016. Mr. Turner has been Senior Vice President of Regulatory Affairs and Quality at Aimmune Therapeutics, Inc. since January 2016 until February 23 2016. Mr. Turner served as Vice President of Regulatory Affairs and Global Quality for Dynavax Technologies Corporation since August 2006. Mr. Turner served as Vice President of Regulatory Affairs of Dynavax Technologies Corp., since August 2006. He has 20 years of regulatory experience including senior positions at Dynavax and Medimmune. He joined Dynavax in August 2006 from Neosil, where he served as Vice President of Regulatory Affairs. He served as a Senior Consultant of the Biologics Consulting Group and Senior Director of Regulatory Affairs of MedImmune Vaccines (formerly, Aviron), and has worked with Allergan, Alpha Therapeutic Corporation, Watson Laboratories, and Gensia Laboratories. Mr. Turner holds a BS in Medical Microbiology with a minor in Chemistry from California State University at Long Beach.